Erratum to: Tumor-infiltrating lymphocytes and molecular response after neoadjuvant therapy for HR+/HER2- breast cancer: results from two prospective trials

M V Dieci; A Frassoldati; D Generali; G Bisagni; F Piacentini; L Cavanna; K Cagossi; F Puglisi; A Michelotti; R Berardi; G Banna; A Goubar; G Ficarra; G Griguolo; Pierfranco Conte; V Guarneri

doi:10.1007/s10549-017-4219-3

Erratum to: Tumor-infiltrating lymphocytes and molecular response after neoadjuvant therapy for HR+/HER2- breast cancer: results from two prospective trials

Breast Cancer Res Treat. 2017 Jun;163(3):637. doi: 10.1007/s10549-017-4219-3.

Authors

M V Dieci^{1

2}, A Frassoldati³, D Generali^{4

5}, G Bisagni⁶, F Piacentini^{7

8}, L Cavanna⁹, K Cagossi¹⁰, F Puglisi^{11

12}, A Michelotti¹³, R Berardi¹⁴, G Banna¹⁵, A Goubar¹⁶, G Ficarra¹⁷, G Griguolo^{1

2}, Pierfranco Conte^{18

19}, V Guarneri^{1

2}

Affiliations

¹ Department of Surgery, Oncology and Gastroenterology, University of Padova, via Giustiniani 2, 35128, Padua, Italy.
² Division of Medical Oncology 2, Istituto Oncologico Veneto IRCCS, via Gattamelata 64, 35128, Padua, Italy.
³ Division of Clinical Oncology, S. Anna University Hospital, via Moro 8, 44100, Cona, Ferrara, Italy.
⁴ Breast UnitASST Cremona, viale Concordia 1, 26100, Cremona, Italy.
⁵ Department of Medical, Surgery & Health Sciences, University of Trieste, Piazza Ospitale 1, 34129, Trieste, Italy.
⁶ Division of Medical Oncology, Azienda Ospedaliera ASMN, IRCSS, Viale Umberto I 50, 42123, Reggio Emilia, Italy.
⁷ Department of Medical and Surgical Sciences of Mother, Child and Adult, University of Modena and Reggio Emilia, Modena, Italy.
⁸ Division of Medical Oncology, Modena University Hospital, via del Pozzo 71, 41124, Modena, Italy.
⁹ Division of Oncology, "Guglielmo da Saliceto" Hospital, via Taverna 49, 29121, Piacenza, Italy.
¹⁰ Division of Medical Oncology, "B.Ramazzini" Hospital, Via Molinari 2, 41012, Carpi, Italy.
¹¹ Department of Medical and Biological Sciences, University of Udine, Udine, Italy.
¹² Department of Oncology, University Hospital of Udine, Piazzale Santa Maria della Misericordia 15, 33010, Udine, Italy.
¹³ UO Oncologia Medica I, Azienda Ospedaliera Universitaria Pisana, Santa Chiara Hospital, via Roma 67, 56126, Pisa, Italy.
¹⁴ Division of Medical Oncology, Università Politecnica delle Marche, Ospedali Riuniti Umberto I, via Conca 71, 60126, Ancona, Italy.
¹⁵ Division of Medical Oncology, Cannizzaro Hospital, via Messina 829, 95126, Catania, Italy.
¹⁶ ICR Clinical Trials and Statistics Unit, 15 Cotswold Road, Sutton, SM2 5NG, UK.
¹⁷ Division of Pathology, Modena University Hospital, via del Pozzo 71, 41124, Modena, Italy.
¹⁸ Department of Surgery, Oncology and Gastroenterology, University of Padova, via Giustiniani 2, 35128, Padua, Italy. [email protected].
¹⁹ Division of Medical Oncology 2, Istituto Oncologico Veneto IRCCS, via Gattamelata 64, 35128, Padua, Italy. [email protected].

PMID: 28374322
DOI: 10.1007/s10549-017-4219-3

No abstract available

Publication types

Published Erratum